Like semaglutide and tirzepatide, it is a glucagon-like peptide-1 (GLP-1) agonist, meaning it acts on GLP-1 receptors just like the natural GLP-1 hormone in your body
Undaria pinnatifida ameliorates nasal inflammation by inhibiting eosinophil and mast cell activation and modulating the NF-B/MAPKs signaling pathway
Currently, BPC 157 is not approved by the FDA for clinical use
Glutathione in cellular redox homeostasis: association with the Excitatory Amino Acid Carrier 1 (EAAC1)
These two peptides are also being researched in the contexts of injuries to the brain, stroke, ALS, and Alzheimers disease, among other conditions
That review also suggests that the weight loss effects may be short-lived due to the way these drugs work